Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC1473965/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC1473965/. The analysis below is for the second page.

Title[redir]:
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4 - PMC
Description:
Previously, we reported our experience treating 14 patients with metastatic melanoma using a fully human antibody to cytotoxic T-lymphocyte antigen-4 (anti–CTLA-4) in conjunction with peptide vaccination. We have now treated 56 patients to evaluate ...

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 6,399,052 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We don’t know how the website earns money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Ncbi.nlm.nih.gov has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

patients, doi, pubmed, google, scholar, response, lung, mgkg, ctla, cells, cohort, autoimmune, patient, antictla, dose, autoimmunity, peptide, toxicity, cell, grade, cancer, treatment, pmc, melanoma, liver, experienced, free, tumor, regression, article, tcell, expression, table, cdcd, antigen, weeks, clinical, disease, mediastinum, immunol, metastatic, treated, vaccination, received, doses, objective, activation, previous, colitis, previously,

Topics {✒️}

granulocyte/macrophage colony-stimulating factor enzyme-linked immuno-spot anti–ctla-4 monoclonal antibody cancer-bearing organs targeted cytotoxic t-lymphocyte antigen-4 enzyme-linked immunosorbent assays fluorescence-activated cell sorter total t-cell/apc interaction selected t-cell markers antagonizes t-cell activation unopposed t-cell activation pmc beta search grade iii/iv toxicity adoptive-cell-transfer therapy studied t-cell receptors cd8 t-cell markers humanized anti–ctla-4 antibody low-dose bolus il-2 bound anti–ctla-4 ab pmc copyright notice cd28 ligand b7/bb1 fully human antibody pg/ml ifn-γ 100 pg/ml ifn-γ remains cancer free selected animal models class ii-restricted peptides primary immune response tetramer-reactive cd8+ cells grade iii/iv received high-dose corticosteroids publisher site pdf t-cell activation enhanced ctla-4 expression antigen-presenting cell fluorochrome-labeled antibodies perivascular lymphocytic infiltrate predominantly lymphocytic infiltrate systemic lupus erythematosus develop effector mechanisms costimulation-dependent activation resected stage iii t-cell receptor showing mononuclear cells serum antithyroglobulin ab develop progressive personality ctla-4-mediated inhibition cell cycle progression cd3+cd8+ intraepithelial lymphocytes t-cell response

Questions {❓}

  • CTLA-4 in autoimmune diseases: A general susceptibility gene to autoimmunity?
  • In the current study, we have treated an additional 15 patients with the 3 mg/kg dose regimen of anti–CTLA-4 originally used, and have treated a second cohort of 27 patients to evaluate whether decreasing the maintenance dose from 3 to 1 mg/kg would reduce the incidence of significant autoimmune toxicity, and if so, would this dose reduction influence the regression of established tumors?

Social Networks {👍}(6)

External Links {🔗}(92)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.58s.